173
Tvardi Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
169
FY23:
116
FY24:
31.7
FY25:
31.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
73.8
FY22:
13.3
FY23:
9.69
FY24:
3.51
FY25:
0.54
Total assets
Change from FY21 to FY25
millions USD
FY21:
247
FY22:
182
FY23:
126
FY24:
35.2
FY25:
32.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
17.6
FY22:
23.5
FY23:
25.6
FY24:
10.4
FY25:
11.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.92
FY22:
0
FY23:
43.2
FY24:
30.5
FY25:
0.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
228
FY22:
159
FY23:
57.1
FY24:
−91.1
FY25:
20.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
247
FY22:
182
FY23:
126
FY24:
–
FY25:
32.1
All amounts in millions USD